TRENTON, N.J. (AP) — Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition and intense pricing pressures.
Merck Buying Schering-Plough in $41B Deal
Previous post: Will Democrats Face a 1994 Repeat in 2010?
Next post: GOP Lacks Leadership on Foreign Policy
